A detailed history of Artisan Partners Limited Partnership transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 306,846 shares of MDGL stock, worth $97.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
306,846
Previous 345,085 11.08%
Holding current value
$97.3 Million
Previous $96.7 Million 32.65%
% of portfolio
0.1%
Previous 0.15%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$212.22 - $292.96 $8.12 Million - $11.2 Million
-38,239 Reduced 11.08%
306,846 $65.1 Million
Q2 2024

Aug 12, 2024

SELL
$193.33 - $291.99 $10.9 Million - $16.5 Million
-56,624 Reduced 14.1%
345,085 $96.7 Million
Q1 2024

May 13, 2024

BUY
$171.37 - $283.23 $18 Million - $29.8 Million
105,229 Added 35.49%
401,709 $107 Million
Q4 2023

Feb 12, 2024

BUY
$120.4 - $237.13 $1.97 Million - $3.89 Million
16,390 Added 5.85%
296,480 $68.6 Million
Q3 2023

Nov 09, 2023

BUY
$146.04 - $225.78 $7.3 Million - $11.3 Million
50,000 Added 21.73%
280,090 $40.9 Million
Q2 2023

Aug 10, 2023

BUY
$203.88 - $312.0 $2.92 Million - $4.47 Million
14,320 Added 6.64%
230,090 $53.2 Million
Q1 2023

May 11, 2023

BUY
$231.06 - $307.08 $804,088 - $1.07 Million
3,480 Added 1.64%
215,770 $52.3 Million
Q4 2022

Feb 10, 2023

BUY
$58.39 - $296.54 $105,569 - $536,144
1,808 Added 0.86%
212,290 $61.6 Million
Q3 2022

Nov 10, 2022

SELL
$60.57 - $79.51 $74,925 - $98,353
-1,237 Reduced 0.58%
210,482 $13.7 Million
Q2 2022

Aug 12, 2022

SELL
$58.04 - $100.2 $702,109 - $1.21 Million
-12,097 Reduced 5.4%
211,719 $15.2 Million
Q1 2022

May 13, 2022

BUY
$55.89 - $101.89 $219,759 - $400,631
3,932 Added 1.79%
223,816 $22 Million
Q4 2021

Feb 11, 2022

SELL
$72.34 - $95.09 $72,701 - $95,565
-1,005 Reduced 0.45%
219,884 $18.6 Million
Q3 2021

Nov 12, 2021

BUY
$78.35 - $105.02 $15,826 - $21,214
202 Added 0.09%
220,889 $17.6 Million
Q2 2021

Aug 12, 2021

BUY
$97.2 - $137.59 $608,666 - $861,588
6,262 Added 2.92%
220,687 $21.5 Million
Q1 2021

May 11, 2021

BUY
$108.54 - $125.2 $439,044 - $506,434
4,045 Added 1.92%
214,425 $25.1 Million
Q4 2020

Feb 10, 2021

BUY
$110.06 - $133.7 $4.09 Million - $4.96 Million
37,120 Added 21.42%
210,380 $23.4 Million
Q3 2020

Nov 12, 2020

BUY
$99.78 - $124.21 $17.3 Million - $21.5 Million
173,260 New
173,260 $20.6 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.42B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.